Title(s): CTSU A151216. Adjuvant Lung Cancer Enrichment Marker Identification and Sequencing Trial (ALCHEMIST)
Investigator(s): Esther Rehmus, MD
Contact Information: McDowell Cancer Research at 330.344.6348

Title(s): CTSU A081105. Randomized Double Blind Placebo Controlled Study of Erlotinib or Placebo in Patients with Completely Resected Epidermal Growth Factor Receptor (EGFR) Mutant Non-small Cell Lung Cancer (NSCLC)
Investigator(s): Esther Rehmus, MD
Contact Information: McDowell Cancer Research at 330.344.6348

Title(s): CTSU E4512. A Phase III Double-Blind Trial for Surgically Resected Early Stage Non-Small Cell Lung Cancer: Crizotinib versus Placebo for Patients with Tumors Harboring the Anaplastic Lymphoma Kinase (ALK) Fusion Protein
Investigator(s): Esther Rehmus, MD
Contact Information: McDowell Cancer Research at 330.344.6348

Title(s): NRG-CC003. Randomized Phase II/III Trial of Prophylactic Cranial Irradiation with or without Hippocampal Avoidance for Small Cell Lung Cancer
Investigator(s): Mitchel Fromm, MD
Contact Information: McDowell Cancer Research at 330.344.6348

Title(s): NRG-LU002. Maintenance Systemic Therapy Versus Consolidative Stereotactic Body Radiation Therapy (SBRT) Plus Maintenance Systemic Therapy for Limited Metastatic Non-Small Cell Lung Cancer (NSCLC): A Randomized Phase II/III Trial
Investigator(s): Mitchel Fromm, MD
Contact Information: McDowell Cancer Research at 330.344.6348

Title(s): S1714 A Prospective Observational Cohort Study to Develop A Predictive Model of Taxane-Induced Peripheral Neuropathy in Cancer Patients
Investigator(s): Sonia Sandhu, MD
Contact Information: McDowell Cancer Research at 330.344.6348

Title(s): S1827 MRI Brain Surveillance Alone Versus MRI Surveillance and Prophylactic Cranial Irradiation (PCI):  A Randomized Phase III Trial in Small-Cell Lung Cancer (MAVERICK)
Investigator(s): Mitchel Fromm, MD
Contact Information: McDowell Cancer Research at 330.344.6348

Title(s): A081801 Integration of immunotherapy into adjuvant therapy for resected NSCLC: ALCHEMIST chemo-IO
Investigator(s): Esther Rehmus, MD
Contact Information: McDowell Cancer Research at 330.344.6348

Title(s): NCICOVID NCI COVID-19 in Cancer Patients Study (N-CCaPS): A Longitudinal Natural History Study
Investigator(s): Esther Rehmus, MD
Contact Information: McDowell Cancer Research at 330.344.6348